Airtime Incentive Amounts to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

A Randomized Controlled Trial of Varying Airtime Incentive Amounts to Improve Interactive Voice Response (IVR) Survey Performance in Bangladesh and Uganda

This study evaluates the effect of two different airtime incentive amounts on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, as compared to control group, in Bangladesh and Uganda.

Study Overview

Detailed Description

Using random digit dialing sampling techniques, the investigators randomized random digit dialed (RDD) participants to one of three airtime incentive amounts contingent on them completing the noncommunicable disease risk factor survey. This mobile phone survey was sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study was conducted in both Bangladesh and Uganda

Study Type

Interventional

Enrollment (Actual)

4233

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dhaka, Bangladesh
        • Institute of Epidemiology Disease Control and Research
      • Kampala, Uganda
        • Makerere University School of Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Bangladesh, conversant in either English or Bangla language. In Uganda, conversant in either Luo, Luganda, Runyakitara, or English Languages

Exclusion Criteria:

  • Less than 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control
No airtime incentive was given for completing the survey
EXPERIMENTAL: 1X incentive
1X airtime incentive
an incentive given in the form of airtime to motivate participants to complete the survey. Participants were given 50 Bangladeshi Taka ($0.60 USD) or 5000 Ugandan Shillings (UGX; $1.35 USD as of April 3, 2018) worth of airtime for completing the survey
EXPERIMENTAL: 2X incentive
2X airtime incentive
an incentive given in the form of airtime to motivate participants to complete the survey. Participants were given 100 Bangladeshi Taka ($1.20 USD) or 10000 UGX ($2.70 USD) worth of airtime for completing the survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cooperation Rate #1
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research,the number of complete interviews divided by the sum of complete interviews, partial interviews, refusals, and breakoffs
Through study completion, an average of one month
Response Rate #4
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research,the number of complete and partial interviews divided by the sum of complete interviews, partial interviews, refusals, breakoffs, and the estimated eligible proportion of unknowns
Through study completion, an average of one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Refusal Rate #2
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research,the number of refusals and break-offs divided by the number of complete interviews, partial interviews, refusals, breakoffs, and the estimated eligible proportion of unknowns
Through study completion, an average of one month
Contact Rate #2
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research,the number of complete and partial interviews, refusals and break-offs divided by the number of complete interviews, partial interviews, refusals, breakoffs, and the estimated eligible proportion of unknowns
Through study completion, an average of one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adnan A Hyder, Phd, MBBS, Johns Hopkins Bloomberg School of Public Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 26, 2017

Primary Completion (ACTUAL)

July 14, 2017

Study Completion (ACTUAL)

July 14, 2017

Study Registration Dates

First Submitted

August 1, 2018

First Submitted That Met QC Criteria

December 5, 2018

First Posted (ACTUAL)

December 7, 2018

Study Record Updates

Last Update Posted (ACTUAL)

December 10, 2018

Last Update Submitted That Met QC Criteria

December 6, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 00007318

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Noncommunicable Diseases

Clinical Trials on 1X airtime incentive

3
Subscribe